Following its presentation to the cardiovascular community, the publication of the SELUTION DeNovo trial marks an important milestone for all teams involved in this ambitious international study.
Conducted across 62 sites in 12 countries and enrolling more than 3,300 patients, SELUTION DeNovo represents years of collaboration between investigators, study teams, sponsors and partners dedicated to advancing evidence in coronary intervention.
As the independent CRO supporting the study, CERC contributed to the successful execution of the trial from study conduct through data management, event adjudication, core laboratory activities, statistical analyses and publication.
Congratulations to the Steering Committee, investigators and all study teams involved, and thank you to Cordis for the collaboration throughout this remarkable project.
Learn more about CERC role in the trial: SELUTION DENOVO : Treatment strategy with DEB plus DES vs DES | CERC
